Abstract
Cell-to-cell communication is an essential process for the efficient function of cells and tissues. Central to this is the purinergic transmission of purines, with ligands such as adenosine triphosphate (ATP). Altered cell-to-cell communication, and in particular changes in the paracrine release of extracellular ATP, plays crucial roles in pathophysiological conditions, such as diabetes. ATP biosensing provides a reliable, real-time measurement of local extracellular ATP concentrations. This allows the detection of altered ATP release, which underlies the progression of inflammation and fibrosis and is a potential therapeutic target. Here we describe in a step-by-step basis how to utilize sensitive microelectrode biosensors to detect low, real-time concentrations of ATP, in vitro.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Burnstock G (2018) The therapeutic potential of purinergic signalling. Biochem Pharmacol 151:157–165. https://doi.org/10.1016/j.bcp.2017.07.016
Prakoura N, Kavvadas P, Chadjichristos CE (2018) Connexin 43: a new therapeutic target against chronic kidney disease. Cell Physiol Biochem 49:998–1009. https://doi.org/10.1159/000493230
Dale N, Frenguelli BG (2012) Measurement of purine release with microelectrode biosensors. Purinergic Signal 8(27):40. https://doi.org/10.1007/s11302-011-9273-4
Wall MJ, Richardson MJE (2015) Localized adenosine signaling provides fine-tuned negative feedback over a wide dynamic range of neocortical network activities. J Neurophysiol 113:871–882. https://doi.org/10.1152/jn.00620.2014
Wall MJ, Dale N (2013) Neuronal transporter and astrocytic ATP exocytosis underlie activity-dependent adenosine release in the hippocampus. J Physiol 591:3853–3871. https://doi.org/10.1113/jphysiol.2013.253450
Price GW, Potter PA, Williams BM et al (2020) Connexin-mediated cell communication in the kidney: a potential therapeutic target for future intervention of diabetic kidney disease? Joan Mott Prize Lecture. Exp Physiol 105:219–229. https://doi.org/10.1113/EP087770
Humphreys BD (2018) Mechanisms of renal fibrosis. Annu Rev Physiol 80:309–326. https://doi.org/10.1146/annurev-physiol-022516-034227
Liu B-C, Tang T-T, Lv L-L, Lan H-Y (2018) Renal tubule injury: a driving force toward chronic kidney disease. Kidney Int 93:568–579. https://doi.org/10.1016/j.kint.2017.09.033
Bosco D, Haefliger J-A, Meda P (2011) Connexins: key mediators of endocrine function. Physiol Rev 91(1393):1445. https://doi.org/10.1152/physrev.00027.2010
Hills CE, Price GW, Squires PE (2015) Mind the gap: connexins and cell–cell communication in the diabetic kidney. Diabetologia 58:233–241. https://doi.org/10.1007/s00125-014-3427-1
Hills C, Price GW, Wall MJ et al (2018) Transforming growth factor Beta 1 drives a switch in Connexin mediated cell-to-cell communication in tubular cells of the diabetic kidney. Cell Physiol Biochem 45:2369–2388. https://doi.org/10.1159/000488185
Siamantouras E, Hills CE, Squires PE, Liu K-K (2016) Quantifying cellular mechanics and adhesion in renal tubular injury using single cell force spectroscopy. Nanomedicine 12:1013–1021. https://doi.org/10.1016/j.nano.2015.12.362
Siamantouras E, Price GW, Potter JA et al (2019) Purinergic receptor (P2X7) activation reduces cell–cell adhesion between tubular epithelial cells of the proximal kidney. Nanomedicine 22:102108. https://doi.org/10.1016/j.nano.2019.102108
Mugisho OO, Green CR, Zhang J et al (2019) Connexin43 hemichannels: a potential drug target for the treatment of diabetic retinopathy. Drug Discov Today 24:1627–1636. https://doi.org/10.1016/j.drudis.2019.01.011
Burnstock G, Knight GE (2018) The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression. Purinergic Signal 14:1–18. https://doi.org/10.1007/s11302-017-9593-0
Price GW Chadjichristos CE, Kavvadas P et al (2020) Blocking connexin-43 mediated hemichannel activity protects against early tubular injury in experimental chronic kidney disease. Cell Commun Signal 18:79. https://doi.org/10.1186/s12964-020-00558-1
Calia G, Rocchitta G, Migheli R et al (2009) Biotelemetric monitoring of brain neurochemistry in conscious rats using microsensors and biosensors. Sensors 9:2511–2523. https://doi.org/10.3390/s90402511
Chirizzi D, Malitesta C (2011) Potentiometric urea biosensor based on urease immobilized by an electrosynthesized poly(o-phenylenediamine) film with buffering capability. Sens Actuators B 157:211–215. https://doi.org/10.1016/j.snb.2011.03.051
Dash MB, Douglas CL, Vyazovskiy VV et al (2009) Long-term homeostasis of extracellular glutamate in the rat cerebral cortex across sleep and waking states. J Neurosci 29:620–629. https://doi.org/10.1523/jneurosci.5486-08.2009
Tian F, Gourine AV, Huckstepp RTR, Dale N (2009) A microelectrode biosensor for real time monitoring of L-glutamate release. Anal Chim Acta 645:86–91. https://doi.org/10.1016/j.aca.2009.04.048
Huckstepp RTR, Eason R, Sachdev A (2010) Dale N CO2-dependent opening of connexin 26 and related β connexins. J Physiol 588:3921–3931. https://doi.org/10.1113/jphysiol.2010.192096
Acknowledgments
The authors acknowledge the generous support of Diabetes UK (PES & CEH: 16/0005427, 16/0005544, and 18/0005919), the Royal Society (CEH), and an EFSD/Boehringer Kidney Award (CEH & PES).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Science+Business Media New York
About this protocol
Cite this protocol
Price, G.W. et al. (2020). Examining Local Cell-to-Cell Signalling in the Kidney Using ATP Biosensing. In: Turksen, K. (eds) Stem Cell Renewal and Cell-Cell Communication. Methods in Molecular Biology, vol 2346. Humana, New York, NY. https://doi.org/10.1007/7651_2020_297
Download citation
DOI: https://doi.org/10.1007/7651_2020_297
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-1569-0
Online ISBN: 978-1-0716-1570-6
eBook Packages: Springer Protocols